Atlas Trials

Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China

Clinical trial NCT04762472 · UNKNOWN

Trial details

NCT number
NCT04762472
Sponsor
Chinese University of Hong Kong
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Atherosclerosis, Coronary
Start date
2023-09-01
Primary completion
2024-12-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.